Last quarter (Q4 2022), Futura Medical's total revenue was £―, a decrease of ― from the same quarter last year. In Q4, Futura Medical's net income was £―. See Futura Medical’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	-	-	-	£ 0.00	£ 31.78K	£ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	-	£ 6.87M	£ 5.87M	£ 2.93M	£ 11.20M	£ 7.27M
Operating Income	-	£ -6.87M	£ -5.87M	£ -2.93M	£ -11.16M	£ -7.27M
Net Non Operating Interest Income Expense	-	-	-	£ 924.00	£ 22.28K	£ 27.58K
Other Income Expense	-	-	-	-	-	-
Pretax Income	-	£ -6.87M	£ -5.87M	£ -2.93M	£ -11.14M	£ -7.24M
Tax Provision	-	£ -1.02M	£ -908.60K	£ -519.09K	£ -2.22M	£ -1.36M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	-	£ -5.85M	£ -4.96M	£ -2.41M	£ -8.92M	£ -5.88M
Basic EPS	-	£ -0.02	£ -0.02	£ >-0.01	£ -0.04	£ -0.04
Diluted EPS	-	£ -0.02	£ -0.02	£ >-0.01	£ -0.04	£ -0.04
Basic Average Shares	-	£ 287.48M	£ 271.05M	£ 243.72M	£ 204.66M	£ 131.94M
Diluted Average Shares	-	£ 287.48M	£ 271.05M	£ 243.72M	£ 204.66M	£ 131.94M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	£ 116.71K	£ 117.28K	£ 114.14K
Total Expenses	-	£ 6.87M	£ -5.87M	£ 2.93M	£ 11.20M	£ 7.27M
Net Income From Continuing And Discontinued Operation	-	£ -5.85M	£ -4.96M	£ -2.41M	£ -8.92M	£ -5.88M
Normalized Income	-	£ -7.90M	£ -6.77M	£ -2.41M	£ -8.92M	£ -5.88M
Interest Expense	-	-	-	-	-	-
EBIT	-	£ -6.87M	£ -5.87M	£ -2.93M	£ -11.16M	£ -7.27M
EBITDA	-	£ -6.85M	£ -5.87M	£ -2.90M	£ -11.14M	£ -7.25M

Currency in GBP

Futura Medical Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing